Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Japanese Encephalitis (JE) Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Japanese Encephalitis (JE) Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Japanese Encephalitis (JE) Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
GSK
Wuhan Institute of Biological
Beijing Taitan
Chengdu institute of biologica
Liaoning Chengda
Valneva
Bharat Biotech
Lanzhou Institute of Biological
By Type:
Inactivated Vaccine
Live Attenuated Vaccine
By End-User:
Public
Private
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Japanese Encephalitis (JE) Vaccine Market
-
1.3 Market Segment by Type
-
1.3.1 China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027
-
1.3.2 China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Public from 2016 to 2027
-
1.4.2 China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Private from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Japanese Encephalitis (JE) Vaccine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Japanese Encephalitis (JE) Vaccine by Major Types
-
3.4.1 Market Size and Growth Rate of Inactivated Vaccine
-
3.4.2 Market Size and Growth Rate of Live Attenuated Vaccine
4 Segmentation of Japanese Encephalitis (JE) Vaccine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Japanese Encephalitis (JE) Vaccine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Japanese Encephalitis (JE) Vaccine in Public
-
4.4.2 Market Size and Growth Rate of Japanese Encephalitis (JE) Vaccine in Private
5 Market Analysis by Regions
-
5.1 China Japanese Encephalitis (JE) Vaccine Production Analysis by Regions
-
5.2 China Japanese Encephalitis (JE) Vaccine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
6.1 North China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
6.2 North China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
7 Central China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
7.1 Central China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
7.2 Central China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
8 South China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
8.1 South China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
8.2 South China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
9 East China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
9.1 East China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
9.2 East China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
10 Northeast China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
10.1 Northeast China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
10.2 Northeast China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
11 Southwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
11.1 Southwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
11.2 Southwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
12 Northwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis
-
12.1 Northwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major Types
-
12.2 Northwest China Japanese Encephalitis (JE) Vaccine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Sanofi
-
13.1.1 Sanofi Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 GSK
-
13.2.1 GSK Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Wuhan Institute of Biological
-
13.3.1 Wuhan Institute of Biological Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Beijing Taitan
-
13.4.1 Beijing Taitan Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Chengdu institute of biologica
-
13.5.1 Chengdu institute of biologica Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Liaoning Chengda
-
13.6.1 Liaoning Chengda Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Valneva
-
13.7.1 Valneva Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Bharat Biotech
-
13.8.1 Bharat Biotech Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Lanzhou Institute of Biological
-
13.9.1 Lanzhou Institute of Biological Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027
-
Figure China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Public from 2016 to 2027
-
Figure China Japanese Encephalitis (JE) Vaccine Market Size and Growth Rate of Private from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Japanese Encephalitis (JE) Vaccine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Japanese Encephalitis (JE) Vaccine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Japanese Encephalitis (JE) Vaccine by Different Types from 2016 to 2027
-
Table Consumption Share of Japanese Encephalitis (JE) Vaccine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Inactivated Vaccine
-
Figure Market Size and Growth Rate of Live Attenuated Vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Japanese Encephalitis (JE) Vaccine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Japanese Encephalitis (JE) Vaccine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Public
-
Figure Market Size and Growth Rate of Private
-
Table China Japanese Encephalitis (JE) Vaccine Production by Regions
-
Table China Japanese Encephalitis (JE) Vaccine Production Share by Regions
-
Figure China Japanese Encephalitis (JE) Vaccine Production Share by Regions in 2016
-
Figure China Japanese Encephalitis (JE) Vaccine Production Share by Regions in 2021
-
Figure China Japanese Encephalitis (JE) Vaccine Production Share by Regions in 2027
-
Table China Japanese Encephalitis (JE) Vaccine Consumption by Regions
-
Table China Japanese Encephalitis (JE) Vaccine Consumption Share by Regions
-
Figure China Japanese Encephalitis (JE) Vaccine Consumption Share by Regions in 2016
-
Figure China Japanese Encephalitis (JE) Vaccine Consumption Share by Regions in 2021
-
Figure China Japanese Encephalitis (JE) Vaccine Consumption Share by Regions in 2027
-
Table North China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table North China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table North China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table North China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure North China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table Central China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table Central China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table Central China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table Central China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure Central China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table South China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table South China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table South China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table South China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure South China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table East China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table East China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table East China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table East China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure East China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table Northeast China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table Northeast China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure Northeast China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table Southwest China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table Southwest China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure Southwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table Northwest China Japanese Encephalitis (JE) Vaccine Consumption by Types from 2016 to 2027
-
Table Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2016
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2021
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by Types in 2027
-
Table Northwest China Japanese Encephalitis (JE) Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2016
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2021
-
Figure Northwest China Japanese Encephalitis (JE) Vaccine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Wuhan Institute of Biological
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wuhan Institute of Biological
-
Figure Sales and Growth Rate Analysis of Wuhan Institute of Biological
-
Figure Revenue and Market Share Analysis of Wuhan Institute of Biological
-
Table Product and Service Introduction of Wuhan Institute of Biological
-
Table Company Profile and Development Status of Beijing Taitan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Taitan
-
Figure Sales and Growth Rate Analysis of Beijing Taitan
-
Figure Revenue and Market Share Analysis of Beijing Taitan
-
Table Product and Service Introduction of Beijing Taitan
-
Table Company Profile and Development Status of Chengdu institute of biologica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chengdu institute of biologica
-
Figure Sales and Growth Rate Analysis of Chengdu institute of biologica
-
Figure Revenue and Market Share Analysis of Chengdu institute of biologica
-
Table Product and Service Introduction of Chengdu institute of biologica
-
Table Company Profile and Development Status of Liaoning Chengda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Liaoning Chengda
-
Figure Sales and Growth Rate Analysis of Liaoning Chengda
-
Figure Revenue and Market Share Analysis of Liaoning Chengda
-
Table Product and Service Introduction of Liaoning Chengda
-
Table Company Profile and Development Status of Valneva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva
-
Figure Sales and Growth Rate Analysis of Valneva
-
Figure Revenue and Market Share Analysis of Valneva
-
Table Product and Service Introduction of Valneva
-
Table Company Profile and Development Status of Bharat Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech
-
Figure Sales and Growth Rate Analysis of Bharat Biotech
-
Figure Revenue and Market Share Analysis of Bharat Biotech
-
Table Product and Service Introduction of Bharat Biotech
-
Table Company Profile and Development Status of Lanzhou Institute of Biological
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute of Biological
-
Figure Sales and Growth Rate Analysis of Lanzhou Institute of Biological
-
Figure Revenue and Market Share Analysis of Lanzhou Institute of Biological
-
Table Product and Service Introduction of Lanzhou Institute of Biological
-
